Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2007
05/02/2007CN1956966A Quinazoline derivatives and therapeutic use thereof
05/02/2007CN1956965A Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high CB1/CB2 receptor subtype selectivity
05/02/2007CN1956964A Tetrahydro-indazole cannabinoid modulators
05/02/2007CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics
05/02/2007CN1956961A Stable crystal form of 4-oxoquinoline compound
05/02/2007CN1956960A Substituted quinoline derivatives as mitotic kinesin inhibitors
05/02/2007CN1956959A Therapeutic compounds: pyridine N oxide scaffold
05/02/2007CN1956958A Aminopyridine derivatives as selective dopamine d3 agonists
05/02/2007CN1956955A Neurogenic pain control agent composition
05/02/2007CN1956954A Novel androgens
05/02/2007CN1956952A Histamine H3 receptor agents, preparation and therapeutic uses
05/02/2007CN1956949A Substituted sulfonamides
05/02/2007CN1956946A Modulators of cannabinoid receptors
05/02/2007CN1956734A Multi-vitamin and mineral nutritional supplements
05/02/2007CN1956732A Antimycobacterial pharmaceutical composition comprising an antitubercular drug
05/02/2007CN1956723A Sulfonylethyl phosphorodiamidates
05/02/2007CN1956722A Improved cytotoxic agents comprising new maytansinoids
05/02/2007CN1956721A Quinazolinone derivatives useful as vanilloid antagonists
05/02/2007CN1956720A Combination medication for treating HIV infection
05/02/2007CN1956719A Specific ppar excitant for treating negative energy equilibrium
05/02/2007CN1956718A Compositions comprising immunomodulatory compounds for the treatment and management of skin diseases and disorders, and method of using the same
05/02/2007CN1956717A Niacin sustained release composition for oral administration
05/02/2007CN1956716A Medicine capable of inhibiting activation of transcription factor KLF5
05/02/2007CN1956715A Novel use of peptide compounds for treating dyskinesia
05/02/2007CN1956714A Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
05/02/2007CN1956713A Agent for preventing/amelioration life style-related diseases containing turmeric essential oil component
05/02/2007CN1956712A Antiviral composition comprising p-menthane-3,8-diol
05/02/2007CN1956711A Peroxisome proliferator-activated receptor (PPAR) activator and drugs, supplements, functional foods and food additives using the same
05/02/2007CN1956710A Methods to relief pain
05/02/2007CN1956709A Dosage form containing the active ingredient cholylsarcosine
05/02/2007CN1956707A Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-D-glutamic acid (LK-423)
05/02/2007CN1956706A Enteric solid oral dosage form of bisphosphonate containing a chelating agent
05/02/2007CN1956704A Skin lightening compositions comprising momordica charantia and pine extract
05/02/2007CN1955280A Potency regeneration cell and culturing method thereof
05/02/2007CN1955187A Roxithromycin derivate and its preparation method and medical application
05/02/2007CN1955183A 20-bit esterified camptothecine derivate, its preparation method and drug composite and use
05/02/2007CN1955182A Purine compound and use as cannabinoid receptor ligands
05/02/2007CN1955181A Purine compound and use as cannabinoid receptor ligands
05/02/2007CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents
05/02/2007CN1955179A [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
05/02/2007CN1955178A New benzimidazole derivative
05/02/2007CN1955177A LAM nucleoside derivate, its preparation method and application
05/02/2007CN1955175A Cumarin derivative and its preparation method and its drug composite and use
05/02/2007CN1955170A Class I tanshinone II A derivative and its application in pharmaceutic
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/02/2007CN1955163A Cyclooxygenase-2 selection inhibitor and its medicine use
05/02/2007CN1955159A Composite for blocking 5-hydroxytryptamine and norepinephrine reabsorbed, its preparation method and its use
05/02/2007CN1955151A Alpha-bulnesene, its preparation and its use
05/02/2007CN1954855A Eye preparation containing sodium hyaluronate for treating fundus macular degeneration and its preparation method
05/02/2007CN1954846A Chinese traditional medicinal anesthetics
05/02/2007CN1954844A Traditional Chinese medicine for treating macous membrane of mouth disease
05/02/2007CN1954839A Medical composite prepared by caulis Marsdeniae Tenacissimae, ginseng and astragalus root
05/02/2007CN1954836A Chinese traditional western compound medicine and its preparation method
05/02/2007CN1954835A Sea-buckthorn plant preparation and its preparation method
05/02/2007CN1954833A Medicine for treating toothache
05/02/2007CN1954832A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954831A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954830A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954829A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954828A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954824A Traditional Chinese medicine eye preparation and its preparation method and quality control method
05/02/2007CN1954823A Medical composite for eye and its preparation method and quality control method
05/02/2007CN1954821A Traditional Chinese composite preparation for treating asthma and its preparation method
05/02/2007CN1954820A Medical composite for treating curdio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954819A Medical composite for treating cardio-cerebral vascular disease and its preparation method and application
05/02/2007CN1954818A Application of phillyrin in preparation for treating endotoxemia
05/02/2007CN1954817A Preparation method of injection type pH and glucose sensitive hydrogel
05/02/2007CN1954816A Quick-slow compound medicine of anti-tuberculosis
05/02/2007CN1954815A Anti-tuberculosis compound medicine quick-slow double-release preparation and its preparation method
05/02/2007CN1954814A Medical composite with co-action for treating gout and its preparation method
05/02/2007CN1954813A Suppository for vagina multi-infection
05/02/2007CN1954812A Use of Edaravone
05/02/2007CN1954811A Oxaliplatin intravenous injection and its preparation method
05/02/2007CN1954810A Preparation method of multi-type superfine naproxen medcine granule
05/02/2007CN1954809A Personal hygiene additive for preventing STD origin of viral and chlamydia
05/02/2007CN1954808A High dose Ambroxol hydrochloride freeze-dried preparation and preparation method
05/02/2007CN1954807A Clomiphene compositions rich in trans-clomiphene
05/02/2007CN1954806A Teprenone orally disintegrating tablet prescription and its preparation method
05/02/2007CN1954805A Application of resorcin compound for preparing antitumor medicine
05/02/2007CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone
05/02/2007CN1954803A Spray-dried granules containing pranlukast and processes for the preparation thereof
05/02/2007CN1954672A Two-and three-component fungicidal mixtures
05/02/2007CN1954671A Two-and three-component fungicidal mixtures
05/02/2007CN1954670A Two-and three-component fungicidal mixtures
05/02/2007CN1313499C Sargassum polysaccharide, its preparation method and use
05/02/2007CN1313476C Injection preparation of arjimycin water soluble phosphate and its preparation method
05/02/2007CN1313475C Use of polygonum cuspidatum tannic acid of polygonum cuspidatum extract in the preparation of medicine for lowering blood sugar and treating diabetes
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
05/02/2007CN1313469C Novel derivative of flavone c-glycoside and composition containing the same
05/02/2007CN1313466C 1,3,4 furodiazole carbon-penillien compound, preparation method and application
05/02/2007CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
05/02/2007CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof
05/02/2007CN1313462C New 3-(4-oxygen-4H-benzopyranyl-2-base)-(1H)-quinoline-4-ketone derivant, its preparing method and drug compositions containing them
05/02/2007CN1313459C Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use
05/02/2007CN1313450C Tachykinin receptor antagonists
05/02/2007CN1313449C New quinazoline hind derivative, medicinal composition containing same and their use
05/02/2007CN1313448C Metalloproteinase inhibitors
05/02/2007CN1313447C 8-azaprostaglandin analogs as agents for lowering intraocular pressure
05/02/2007CN1313441C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
05/02/2007CN1313439C Compounds and compositions for delivering active agents
1 ... 3775 3776 3777 3778 3779 3780 3781 3782 3783 3784 3785 3786 3787 3788 3789 3790 3791 3792 3793 3794 3795 ... 7860